Drug class
Proton Pump Inhibitors
Proton pump inhibitors are a therapeutic class of antisecretory medications that produce potent and prolonged suppression of gastric acid production. Read more about Proton Pump Inhibitors
306 drugs in this class 139 manufacturers
Drugs in Proton Pump Inhibitors
OMEPRAZOLE
OMEPRAZOLE
OMEPRAZOLE
ACID REDUCER (famotidine)
OMEPRAZOLE MAGNESIUM
OMEPRAZOLE MAGNESIUM
OMEPRAZOLE MAGNESIUM
LANSOPRAZOLE
Proton pump inhibitors are a therapeutic class of antisecretory medications that produce potent and prolonged suppression of gastric acid production.
They function by covalently binding to and irreversibly inhibiting the gastric hydrogen-potassium ATPase enzyme system, commonly referred to as the proton pump, on the secretory surface of stomach parietal cells to block the final step of acid secretion.
Agents in this class are widely indicated for acid-related gastrointestinal conditions, including gastroesophageal reflux disease, erosive esophagitis, gastric and duodenal peptic ulcer disease, Helicobacter pylori eradication regimens, and pathological hypersecretory states such as Zollinger-Ellison syndrome.
-
nih.gov
Proton pump inhibitors are a therapeutic class of antisecretory medications that produce potent and prolonged suppression of gastric acid production They function by covalently binding to and irreversibly inhibiting the gastric hydrogen-potassium ATPase enzyme system, commonly referred to as the proton pump, on the secretory surface of stomach parietal cells to block the final step of acid secretion
-
nih.gov
Proton pump inhibitors are a therapeutic class of antisecretory medications that produce potent and prolonged suppression of gastric acid production They function by covalently binding to and irreversibly inhibiting the gastric hydrogen-potassium ATPase enzyme system, commonly referred to as the proton pump, on the secretory surface of stomach parietal cells to block the final step of acid secretion
-
nih.gov
Agents in this class are widely indicated for acid-related gastrointestinal conditions, including gastroesophageal reflux disease, erosive esophagitis, gastric and duodenal peptic ulcer disease, Helicobacter pylori eradication regimens, and pathological hypersecretory states such as Zollinger-Ellison syndrome
-
fepblue.org
Agents in this class are widely indicated for acid-related gastrointestinal conditions, including gastroesophageal reflux disease, erosive esophagitis, gastric and duodenal peptic ulcer disease, Helicobacter pylori eradication regimens, and pathological hypersecretory states such as Zollinger-Ellison syndrome
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.